Puriblood Medical Co., Ltd. (TPEX:6847)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
88.70
+0.60 (0.68%)
Jun 3, 2026, 1:52 PM CST
Market Cap1.26B +10.3%
Revenue (ttm)82.34M -25.6%
Net Income-39.00M
EPS-2.74
Shares Out 14.23M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume105,189
Open88.10
Previous Close88.10
Day's Range81.80 - 92.50
52-Week Range47.75 - 93.70
Beta0.12
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Puriblood Medical

Puriblood Medical Co., Ltd. engages in the research and development of blood purification-related medical devices in Taiwan. The company offers leukoreduction, cell separation, and P-Tex, an advanced anti-fouling technology, which is composed by bio-inspired molecular formula. It is also involved in animal blood transfusion. Puriblood Medical Co., Ltd. was incorporated in 2015 and is based in Hsinchu City, Taiwan. [Read more]

Sector Healthcare
Founded 2015
Employees 44
Stock Exchange Taipei Exchange
Ticker Symbol 6847
Full Company Profile

Financial Performance

In 2025, Puriblood Medical's revenue was 82.34 million, a decrease of -25.61% compared to the previous year's 110.67 million. Losses were -39.00 million, 626.7% more than in 2024.

Financial Statements